p21 Waf1/Cip1 siRNA II - CD BioSciences

service-banner

p21 Waf1/Cip1 siRNA II

p21 Waf1/Cip1 siRNA II

SPR-00742

Size Price
1 Unit Online Inquiry
Target Information
Target Name p21 Waf1/Cip1
Gene Abbr. CDKN1A
Gene ID 1026
Full Name cyclin dependent kinase inhibitor 1A
Alias CAP20, CDKN1, CIP1, MDA-6, P21
Introduction The tumor suppressor protein p21 Waf1/Cip1 acts as an inhibitor of cell cycle progression. It functions in stoichiometric relationships forming heterotrimeric complexes with cyclins and cyclin-dependent kinases. In association with CDK2 complexes, it serves to inhibit kinase activity and block progression through G1/S. However, p21 may also enhance assembly and activity in complexes of CDK4 or CDK6 and cyclin D. The carboxy-terminal region of p21 is sufficient to bind and inhibit PCNA, a subunit of DNA polymerase, and may coordinate DNA replication with cell cycle progression. Upon UV damage or during cell cycle stages when cdc2/cyclin B or CDK2/cyclin A are active, p53 is phosphorylated and upregulates p21 transcription via a p53-responsive element. Protein levels of p21 are downregulated through ubiquitination and proteasomal degradation.
Usage
Application RNA interference
Reactivity
Storage & Handling
Storage Buffer The siRNA product is supplied in RNAse-free water.
Storage Temp. Aliquot and store at -20 °C.

For research use only. Not intended for any clinical use. No products from CD BioSciences may be resold, modified for resale or used to manufacture commercial products without prior written approval from CD BioSciences.